Neuraxpharm participates in ECTRIMS, reinforcing its commitment to multiple sclerosis Barcelona, Spain and Düsseldorf, ...

However, there could be many more because dystonia is one of the most widely underdiagnosed movement disorders. It is often ...

In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.

When we think of movement disorders, the tremors associated with Parkinson's disease are probably what first spring to mind.

Learn how the acoustic startle response serves as a powerful tool for assessing reflex pathways and neural function.

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced ...

According to IQVIA ® U.S. annual sales for bimatoprost ophthalmic solution 0.01% for the 12 months ended July 2025 were approximately $685 million. Note: LUMIGAN ® is a registered trademark of ...

Alli McCartney of UBS noted that the market’s behavior after the recent Fed rate cut was unusual. On the day of the cut, major indices closed lower except for the Russell 2000.

We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Relmada Therapeutics, Inc. is one of them. Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotechnology ...

GCCL, a global clinical trial sample analysis organization, announced on September 22 that on the 19th, it signed a ...